Ruconest Disease Interactions
There is 1 disease interaction with Ruconest (conestat alfa).
Conestat alfa (applies to Ruconest) thromboembolism
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: History - Thrombotic/Thromboembolic Disorder, Thrombotic/Thromboembolic Disorder
Serious arterial and venous thromboembolic (TE) events have been reported at the recommended dose of plasma derived conestat alfa. Patients with risk factors such as, prior history of thrombosis might be at an increased risk. It is recommended to monitor patients with known risk factors for TE events during and after therapy administration.
References (1)
- (2015) "Product Information. Ruconest (conestat alfa)." Valeant Pharmaceuticals
Switch to consumer interaction data
Ruconest drug interactions
There are 50 drug interactions with Ruconest (conestat alfa).
More about Ruconest (conestat alfa)
- Ruconest consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Firazyr
Firazyr is used to treat acute attacks of hereditary angioedema (HAE) in adults. It can be ...
Cinryze
Cinryze (complement C1 esterase inhibitor) is used to prevent attacks of angioedema in people with ...
Orladeyo
Orladeyo (berotralstat) is used to prevent attacks of hereditary angioedema (HAE). Includes ...
Haegarda
Haegarda is an injectable protein replacement therapy that prevents swelling and attacks in ...
Takhzyro
Takhzyro (lanadelumab-flyo) is used to prevent hereditary angioedema (HAE) and reduce symptoms ...
Berinert
Berinert is used to treat acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks ...
Icatibant
Icatibant is an injection used to treat acute attacks of hereditary angioedema (HAE) in adults. It ...
Lanadelumab
Lanadelumab injection is a monoclonal antibody used to prevent hereditary angioedema. Includes side ...
Stanozolol
Stanozolol is used in the treatment of hereditary angioedema, which causes episodes of swelling of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.